Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $14.68, but opened at $13.68. Terumo shares last traded at $13.68, with a volume of 234 shares.

Analyst Ratings Changes

Separately, Nomura raised Terumo from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Terumo has an average rating of “Buy”.

Terumo Stock Performance

The stock has a fifty day moving average of $15.01 and a 200 day moving average of $14.07. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.19. The company has a market capitalization of $20.93 billion, a PE ratio of 19.99 and a beta of 0.68.

Terumo (OTCMKTS:TRUMY) last released its earnings results on Friday, August 7th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.17 by $0.13. The firm had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a net margin of 13.83% and a return on equity of 10.44%. As a group, sell-side analysts predict that Terumo Corp. will post 0.7 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions.